PRE earnings: next report 2026-09-11, real EPS beat/miss history, analyst consensus Buy, P/E -4.77. Updated 2026-07-23.
Prenetics Global (PRE) Research Hub
Prenetics Global (PRE) trades on NASDAQ, HK in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-09-11, shares last closed at 23.47 USD (-3.30%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.77, market cap 0.38B. This hub links to the full technical, earnings and options research available for PRE.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, HK |
| Last close | 23.47 USD (-3.30%) |
| 52-week range | 16.26 USD – 26.58 USD |
| Trend regime | Range |
| 14-day RSI | 71.4 (Overbought) |
| Trailing P/E | -4.77 |
| Market cap | 0.38B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-11 |
Available research for PRE
Covered Call on PRE: how it works, illustrative setup around the real 23.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PRE: how it works, illustrative setup around the real 23.47 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PRE: how it works, illustrative setup around the real 23.47 USD price, max profit/loss, breakeven and when to use it. Educational.
PRE technical analysis: range, last 23.47 USD, RSI 71.4, 52w range 16.26 USD–26.58 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is PRE in?
Prenetics Global (PRE) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, HK.
Is PRE in an uptrend or downtrend?
As of 2026-09-11, PRE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PRE's trailing P/E ratio?
PRE's trailing P/E is -4.77, with a market cap of 0.38B. See the earnings research page for full valuation detail.
When does PRE next report earnings?
PRE is next scheduled to report earnings on 2026-09-11, with a consensus EPS estimate of -0.48 USD.